Abstract
The use of extracorporeal membrane oxygenation in the management of ARDS has grown considerably in the past decade, largely as a consequence of improvements in extracorporeal technology and management techniques. Recently published data has helped clarify the use of ECMO in ARDS, and its role in optimizing lung-protective ventilation and minimizing ventilator-induced lung injury has the potential to have a substantial impact on ARDS management and outcomes. In the future, novel extracorporeal management strategies may lead to a new paradigm in our approach to patients with ARDS. Key words: ARDS; extracorporeal membrane oxygenation (ECMO); respiratory failure; extracorporeal life support. [Respir Care 2018;63(9):1180–1188.
Original language | English (US) |
---|---|
Pages (from-to) | 1180-1188 |
Number of pages | 9 |
Journal | Respiratory care |
Volume | 63 |
Issue number | 9 |
DOIs | |
State | Published - Sep 1 2018 |
Externally published | Yes |
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine